Skip to main content

Peer Review reports

From: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Original Submission
5 Aug 2020 Submitted Original manuscript
26 Aug 2020 Reviewed Reviewer Report - Kirsty Loudon
22 Sep 2020 Reviewed Reviewer Report - Hakim-Moulay Dehbi
23 Oct 2020 Author responded Author comments - Thomas Vanassche
Resubmission - Version 2
23 Oct 2020 Submitted Manuscript version 2
1 Nov 2020 Reviewed Reviewer Report - Kirsty Loudon
2 Nov 2020 Reviewed Reviewer Report - Hakim-Moulay Dehbi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Nov 2020 Editorially accepted
9 Dec 2020 Article published 10.1186/s13063-020-04878-y

You can find further information about peer review here.

Back to article page